The Unlikely Connection Between Ozempic and Clear Airways A recent study published by researchers from Imperial College London has found an intriguing link between the use of semaglutide, a medication used to treat type 2 diabetes, and reduced asthma attacks.
The analysis of over 80,000 patient records in the UK revealed that those taking GLP 1 receptor agonists like semaglutide experienced significantly fewer flare ups of respiratory conditions such as asthma and chronic obstructive pulmonary disease (COPD).
This correlation is significant because it suggests a potential new use for medications like Ozempic, which has primarily been marketed as a treatment for obesity and diabetes.